30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Bodenstedt Matthias

Track

Insider profile

Performance

Overall performance
3.2
Performance over holding periods
3.2
30 days 90 days 120 days
Average return 17% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Bodenstedt Matthias's trades of MoonLake Immunotherapeutics's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-13 2026-05-11
PlS Planned sale
28,074 -34.6%
208.29
US$4,323,421 		28,074 -34.6% 208.29 US$4,323,421
2026-04-16 2026-04-14
PlS Planned sale
23,147 -49.7%
461.18
US$465,434 		23,147 -49.7% 461.18 US$465,434
2026-04-10 2026-04-10
PlS Planned sale
58,247 -29.1%
208.93
US$491,635 		58,247 -29.1% 208.93 US$491,635
2026-04-10 2026-04-09
PlS Planned sale
85,870 -6.7%
18.94
US$1,626,378 		85,870 -6.7% 18.94 US$1,626,378
2026-04-09 2026-04-09
PrS Proposed sale
160,870
18.46
US$2,969,660 		160,870 18.46 US$2,969,660
2025-10-09 2025-10-08
B Purchase
10,870 +1.8%
9.09
US$98,808 		10,870 +1.8% 9.09 US$98,808
2023-12-21 2023-12-20
PlS Planned sale
5,264 -1.0%
58.34
US$307,102 		5,264 -1.0% 58.34 US$307,102
2023-12-20 2023-12-20
PrS Proposed sale
5,264
59.27
US$311,997 		5,264 59.27 US$311,997
2023-12-21 2023-12-19
PlS Planned sale
94,736 -15.3%
59.22
US$5,610,266 		94,736 -15.3% 59.22 US$5,610,266
2023-12-19 2023-12-19
PrS Proposed sale
94,736
59.22
US$5,610,266 		94,736 59.22 US$5,610,266